SCHEMBL13848993

SCHEMBL13848993

CCC(=O)c1cnn(-c2ccccc2)c1CC

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A3 Q92570 1/20 0.78
MAPK1 P28482 2/20 0.51
ALDH1A1 P00352 5/20 0.50
HPGD P15428 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.49
MAPT P10636 3/20 0.49
POLB P06746 1/20 0.49
NPC1 O15118 1/20 0.48
NFKB1 P19838 1/20 0.48
RAB9A P51151 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
KEAP1 Q14145 1/20 0.48
NFE2L2 Q16236 1/20 0.48
RIPK2 O43353 1/20 0.48
GAA P10253 1/20 0.47
KDM4E B2RXH2 1/20 0.47
HSD11B1 P28845 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MAPK14 Q16539 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4036784 0.88 NR4A3 (0.74) NR4A3MAPK1ALDH1A1HPGDSMN1; SMN2
SCHEMBL1905624 0.88 NR4A3 (1.00) NR4A3MAPK1ALDH1A1HPGDSMN1; SMN2
SCHEMBL4034195 0.86 NR4A3 (0.80) NR4A3MAPK1ALDH1A1HPGDSMN1; SMN2
SCHEMBL30153787 0.85 NR4A3 (0.78) NR4A3MAPK1ALDH1A1HPGDSMN1; SMN2
SCHEMBL19902355 0.83 MAPK1 (0.69) NR4A3MAPK1ALDH1A1HPGDSMN1; SMN2
SCHEMBL1907312 0.82 NR4A3 (0.74) NR4A3MAPK1ALDH1A1HPGDSMN1; SMN2
SCHEMBL20250838 0.82 NR4A3 (0.56) NR4A3MAPK1ALDH1A1HPGDSMN1; SMN2
SCHEMBL13887595 0.81 NR4A3 (0.72) NR4A3MAPK1ALDH1A1HPGDSMN1; SMN2
SCHEMBL14310927 0.79 MAPT (0.74) NR4A3MAPK1ALDH1A1HPGDSMN1; SMN2
SCHEMBL3715104 0.79 SLC9A1 (0.70) NR4A3MAPK1ALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1725544-B1 3-[4-HETEROCYCLYL-1,2,3-TRIAZOL-1-YL]-N-ARYL-BENZAMIDES AS INHIBITORS OF THE CYTOKINES PRODUCTION FOR THE TREATMENT OF CHRONIC INFLAMMATORY DISEASES BOEHRINGER INGELHEIM PHARMA (US) 2009-05-27 EP disclosed